Egypt launches first Large-Scale NF1 registry to uncover disease patterns

NCT ID NCT07221331

First seen Nov 01, 2025 · Last updated May 29, 2026 · Updated 23 times

Summary

This study is a disease registry that will collect information from 200 people in Egypt who have neurofibromatosis type 1 (NF1), a genetic condition that causes tumors to grow on nerves. The goal is to learn how NF1 progresses over time, what treatments patients receive, and how the disease affects their lives. No new treatments are being tested; instead, researchers will review medical records to better understand NF1 in the Egyptian population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Al Mansurah, Egypt

  • Research Site

    RECRUITING

    Alexandria, Egypt

  • Research Site

    RECRUITING

    Aswān, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Asyut, Egypt

  • Research Site

    RECRUITING

    Cairo, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Cairo, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Sohag, Egypt

  • Research Site

    RECRUITING

    Tanta, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Zagazig, Egypt

Conditions

Explore the condition pages connected to this study.